Kangtai Biological Partners with Pakistani Firm for Pneumonia Vaccine Expansion
China-based Shenzhen Kangtai Biological Products Co., Ltd (SHE: 300601) has announced a strategic partnership with...
China-based Shenzhen Kangtai Biological Products Co., Ltd (SHE: 300601) has announced a strategic partnership with...
Shanghai-based REMD, a leading manufacturer of irreversible electroporation devices, has reportedly raised over RMB 100...
The National Medical Products Administration (NMPA) has granted approval to Jiangsu Carephar Pharmaceutical Co., Ltd’s...
US-based Organon Inc. (NYSE: OGN) has released its Q4 and full-year 2022 financial results. Global...
China-based Hong Kong WinHealth Pharma Group Ltd’s Bo’Ao Winhealth Rare Disease Medical Center has accessed...
Germany-based life sciences service provider Eppendorf is set to begin work on a new production...
Beijing InnoCare Pharma Tech Co., (HKG: 9969), a China-based biotech focusing on cancer and autoimmune...
China-based AIM Vaccine Co., Ltd (HKG: 6660) has announced receiving separate approvals in Pakistan to...
China-based Innovent Biologics (HKG: 1801) has announced the first subject dosing in the Phase III...
Sino-US gene therapy specialist Frontera Therapeutics has announced the first patient dosing in a clinical...
China-based Chengdu Kanghong Pharmaceutical Group Co., Ltd (SHE: 002773) has announced receiving an Orphan Drug...
China-based Luye Pharma Group (HKG: 2186) has announced the first subject dosing in a Phase...
The Center for Drug Evaluation (CDE) website indicates that a clinical trial filing for RNK05047,...
Shanghai Junshi Biosciences Co., Ltd (HKG: 1877, SHA: 688180) and its US partner Coherus BioSciences...
US-based Eyenovia Inc., (NASDAQ: EYEN) has announced a strategic development and collaboration agreement with Taiwan-based...
China’s Brii Biosciences (HKG: 2137) has announced the publication of interim results from a Phase...
Jiangsu Hengrui Pharmaceuticals (SHA: 600276) has announced receiving the go-ahead from the National Medical Products...
China-based Grand Pharmaceutical Group Limited (HKG: 0512) has announced the successful completion of the first...
Suzhou Zelgen Biopharmaceuticals Co., Ltd (SHA: 688266) has announced that separate clinical trial filings for...
China-based Innovent Biologics Inc., (HKG: 1801) has announced the first patient dosing in a Phase...